secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0000950170-25-042005
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics Q4 revenue $24k; PRIME study meets primary endpoints; raised $57.5M
--------------------------------------------------------------------------------

- Q4 2024 revenue $24,000; net loss $8.6M vs $7.9M prior year.
- PRIME study: 25% reduction in neonatal morbidity/mortality index and 18% reduction in length of stay in modified ITT.
- Full year 2024 revenue $77,000; net loss $32.9M vs $36.2M in 2023.
- Raised $57.5M in Feb 2025 public offering; cash runway extended through 2028.
- R&D expenses $3.1M in Q4, down 19% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000095017025042005/0000950170-25-042005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000095017025042005/sera-20250319.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-042005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer